Publicity into the glucuronide metabolite is 35 to 40 times better than exposure into the mum or dad drug. In vitro facts advise that hydromorphone in clinically suitable concentrations has negligible potential to inhibit the activity of human hepatic CYP450 enzymes which include CYP1A2, 2C9, 2C19,